1. Epigenetics
    TGF-beta/Smad
  2. PKC
  3. LXS196

LXS196 

Cat. No.: HY-101569 Purity: 99.68%
Handling Instructions

LXS196 est un inhibiteur de la protéine kinase C (PKC) qui est puissant, sélectif et oralement actif , avec des valeurs IC50 de 1,9 nM, 0,4 nM et 3,1 μM pour PKCα, PKCθ et GSK3β , respectivement. LXS196 a le potentiel pour la recherche sur le mélanome uvéal.

LXS196 is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 μM for PKCα, PKCθ and GSK3β, respectively. LXS196 has the potential for uveal melanoma research.

For research use only. We do not sell to patients.

LXS196 Chemical Structure

LXS196 Chemical Structure

CAS No. : 1874276-76-2

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply Now  
10 mM * 1 mL in DMSO USD 161 In-stock
Estimated Time of Arrival: December 31
2 mg USD 80 In-stock
Estimated Time of Arrival: December 31
5 mg USD 155 In-stock
Estimated Time of Arrival: December 31
10 mg USD 235 In-stock
Estimated Time of Arrival: December 31
25 mg USD 409 In-stock
Estimated Time of Arrival: December 31
50 mg USD 610 In-stock
Estimated Time of Arrival: December 31
100 mg USD 920 In-stock
Estimated Time of Arrival: December 31
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

LXS196 is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 μM for PKCα, PKCθ and GSK3β, respectively. LXS196 has the potential for uveal melanoma research[1][2].

IC50 & Target

PKCα

1.9 nM (IC50)

PKCθ

0.4 nM (IC50)

GSK3β

3.1 μM (IC50)

In Vitro

Upon oral administration, protein kinase C inhibitor LXS196 binds to and inhibits PKC, which prevents the activation of PKC-mediated signaling pathways. This may lead to the induction of cell cycle arrest and apoptosis in susceptible tumor cells. PKC, a serine/threonine protein kinase overexpressed in certain types of cancer cells, is involved in tumor cell differentiation, proliferation, invasion and survival[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

LXS196 (compound 9) (15, 30, 75, 150 mg/kg, P.O., mice) shows improved efficacy (regression) in a 92.1 GNAQ uveal melanoma xenograft model in a dose-dependently manner[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mice implanted with 92.1 GNAQ mutant uveal melanoma cells[2].
Dosage: 15, 30, 75, 150 mg/kg
Administration: P.O. (bid) for 35 days
Result: Dose-dependently suppressed the tumor growth.
Clinical Trial
Molecular Weight

472.47

Formula

C₂₂H₂₃F₃N₈O

CAS No.

1874276-76-2

SMILES

NC1=C(C(NC2=C(N3CCC(C)(N)CC3)C=CC=N2)=O)N=C(C4=NC=CC=C4C(F)(F)F)C=N1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 25 mg/mL (52.91 mM; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.1165 mL 10.5827 mL 21.1654 mL
5 mM 0.4233 mL 2.1165 mL 4.2331 mL
10 mM 0.2117 mL 1.0583 mL 2.1165 mL
*Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (5.29 mM); Clear solution

  • 2.

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (5.29 mM); Clear solution

  • 3.

    Add each solvent one by one:  10% DMSO    90% corn oil

    Solubility: ≥ 2.5 mg/mL (5.29 mM); Clear solution

*All of the co-solvents are provided by MCE.
References

Purity: 99.68%

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Keywords:

LXS196LXS 196LXS-196PKCProtein kinase CInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email address *

Phone number *

 

Organization name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
LXS196
Cat. No.:
HY-101569
Quantity:
MCE Japan Authorized Agent: